Pure Global
NCT05793801

Study of the Impact of Frequency of Changing PICCline Dressings in Patients With Acute Leukemia

Centre Hospitalier Universitaire de Nīmes·ClinicalTrials.gov·otherRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Leukemia
Drug/Device/Intervention
Dressing change
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Centre Hospitalier Universitaire de Nīmes
Location
Montpellier, France
Timeline & enrollment
Phase
N/A
Start date
Jun 06, 2023
End date
Sep 01, 2024
Enrollment
60 participants
Primary outcome

Rate of local and/or systemic occurrence of infection on the PICCline in controls,Rate of local and/or systemic occurrence of infection on the PICCline in controls,Rate of local and/or systemic occurrence of infection on the PICCline in controls,Rate of local and/or systemic occurrence of infection on the PICCline in controls,Rate of local and/or systemic occurrence of infection on the PICCline in controls,Rate of local and/or systemic occurrence of infection on the PICCline in controls,Rate of local and/or systemic occurrence of infection on the PICCline in controls,Rate of local and/or systemic occurrence of infection on the PICCline in controls,Rate of local and/or systemic occurrence of infection on the PICCline in controls,Rate of local and/or systemic occurrence of infection on the PICCline in the experimental group,Rate of local and/or systemic occurrence of infection on the PICCline in the experimental group,Rate of local and/or systemic occurrence of infection on the PICCline in the experimental group,Rate of local and/or systemic occurrence of infection on the PICCline in the experimental group,Rate of local and/or systemic occurrence of infection on the PICCline in the experimental group,Rate of local and/or systemic occurrence of infection on the PICCline in the experimental group,Rate of local and/or systemic occurrence of infection on the PICCline in the experimental group,Rate of local and/or systemic occurrence of infection on the PICCline in the experimental group,Rate of local and/or systemic occurrence of infection on the PICCline in the experimental group,Rate of local and/or systemic occurrence of infection on the PICCline in the experimental group,Rate of local and/or systemic occurrence of infection on the PICCline in the experimental group,Rate of local and/or systemic occurrence of infection on the PICCline in the experimental group,Rate of local and/or systemic occurrence of infection on the PICCline in the experimental group,Rate of local and/or systemic occurrence of infection on the PICCline in the experimental group,Rate of local and/or systemic occurrence of infection on the PICCline in the experimental group,Rate of local and/or systemic occurrence of infection on the PICCline in the experimental group,Rate of local and/or systemic occurrence of infection on the PICCline in the experimental group,Rate of local and/or systemic occurrence of infection on the PICCline in the experimental group,Rate of local and/or systemic occurrence of infection on the PICCline in the experimental group,Rate of local and/or systemic occurrence of infection on the PICCline in the experimental group,Rate of local and/or systemic occurrence of infection on the PICCline in the experimental group,Rate of local and/or systemic occurrence of infection on the PICCline in the experimental group,Rate of local and/or systemic occurrence of infection on the PICCline in the experimental group,Rate of local and/or systemic occurrence of infection on the PICCline in the experimental group,Rate of local and/or systemic occurrence of infection on the PICCline in the experimental group,Rate of local and/or systemic occurrence of infection on the PICCline in the experimental group,Rate of local and/or systemic occurrence of infection on the PICCline in the experimental group,Rate of local and/or systemic occurrence of infection on the PICCline in the experimental group,Rate of local and/or systemic occurrence of infection on the PICCline in the experimental group,Rate of local and/or systemic occurrence of infection on the PICCline in the experimental group

Summary

Peripherally Inserted Central Catheters have been widely used for many years for the
 administration of chemotherapy to patients with cancer. However, its use entails significant
 infectious complications and high risks of death.The hypothesis is that increasing the rate
 of PICCline dressing changes will reduce the occurrence of catheter-related infections.

ICD-10 classifications
Leukaemia, unspecifiedMyeloid leukaemiaMyeloid leukaemia, unspecifiedOther myeloid leukaemiaMonocytic leukaemia, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05793801
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05793801 through Pure Global AI's free database. This phase not specified trial is sponsored by Centre Hospitalier Universitaire de Nīmes and is currently Recruiting. The study focuses on Leukemia. Target enrollment is 60 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.